Sullivan Kaede V
Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine at Temple University, Temple University Health System, Philadelphia, Pennsylvania.
Clin Microbiol Newsl. 2017 Aug 15;39(16):125-129. doi: 10.1016/j.clinmicnews.2017.08.001. Epub 2017 Aug 9.
In the clinical microbiology laboratory, the focus when choosing new tests is often on performance, turnaround time, and labor needs. This review examines available rapid, multiplexed tests from a different perspective: that of the patient. It considers whether published evidence supports the notion that use of rapid, on-demand tests (as opposed to batched testing) leads to better patient outcomes and whether broad, syndrome-based, multiplexed panels translate into better patient care than narrower monoplex or duplex assays. Finally, we examine how synergy between the clinical microbiology and antimicrobial stewardship programs is necessary to ensure that rapid tests, if implemented, impact the patients they are designed to support.
在临床微生物学实验室中,选择新检测方法时通常关注的是性能、周转时间和人力需求。本综述从不同角度审视了现有的快速、多重检测方法:患者角度。它探讨了已发表的证据是否支持以下观点,即使用快速、即时检测方法(与批量检测相对)能带来更好的患者预后,以及基于综合征的广泛多重检测组合是否比更窄的单重或双重检测方法能为患者提供更好的护理。最后,我们研究了临床微生物学与抗菌药物管理计划之间的协同作用如何必要,以确保如果实施快速检测,能对其旨在支持的患者产生影响。